FDA Inks Class II Designation For Embryo Viability Tests
This article was originally published in The Gray Sheet
Executive Summary
The agency set a class II with special controls designation for assisted reproduction embryo image assessment systems in a Feb. 26 final order, following the de novo decision for Auxogyn’s Eeva system last summer.